CTV
FY2026 EPS Estimate
$0.06
FY2026E EPS$0.06

Analyst Sentiment

Wall St. Consensus
Buy
4 analysts·Low coverage
63
Score
2 Buy (50%)2 Hold (50%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
250%
Hold
250%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.50
-20.4%
Consensus
$2.50
-20.4%
Bull
$2.50
-20.4%
12-Month Target Range4 analysts
$2.50$2.50$2.50
Current $3.14Consensus
Current Price
$3.14
Above Consensus
$0.64

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026E
Revenue Avg$183M
Low$183M
High$183M
EBITDA Avg$23M
Low$11M
High$31M
EBIT Avg$12M
Low$76,296
High$21M
Net Income Avg$9M
Low$-1M
High$15M
EPS Avg$0.06
Low$-0.01
High$0.11
Analysts (Rev / EPS)3 / 3

Earnings Surprises

Recent Analyst Actions

Jul 23, 2024Morgan Stanley
Innovid price target raised to $2.50 from $2.20 at Morgan Stanley
Target:$2.50
+23.2%from $2.03
Apr 16, 2024Morgan Stanley
Innovid price target raised to $2.10 from $1.60 at Morgan Stanley
Target:$2.10
-5.8%from $2.23
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.